|Day's Range||116.37 - 116.77|
|52 Week Range||102.07 - 121.24|
|PE Ratio (TTM)||-60.78|
|Expense Ratio (net)||0.20%|
In 2016, Merck’s (MRK) ProQuad reported revenues of ~$495 million, which reflected 9% year-over-year growth.
In 2016, Merck’s Janumet (sitagliptin and metformin HCl) reported revenues of around $2.2 billion, which reflected ~2% YoY growth.
Abbott Laboratories (ABT) reported about $1.6 billion of revenues from its Nutrition segment, representing a YoY (year-over-year) fall of ~1.0%.